Biofilm/Persister/Stationary Phase Bacteria Cause More Severe Disease Than Log Phase Bacteria – I Biofilm Borrelia burgdorferi Not Only Display More Tolerance to Lyme Antibiotics But Also Cause More Severe Pathology In a Mouse Arthritis Model: Implications for Understanding Persistence, PTLDS and Treatment Failure

作者: Rebecca Yee , Ying Zhang , Tingting Li , Jie Feng , Yuting Yuan

DOI: 10.1101/440461

关键词:

摘要: Abstract Lyme disease, caused by Borrelia burgdorferi, is the most common tick-borne illness in US and Europe. While patients can be cured with a 2-4 week antibiotic therapy, about 10%-20% continue to suffer persistent symptoms of fatigue, pain or joint muscle aches, neurocognitive despite treatment, condition called post-treatment disease syndrome (PTLDS). The cause for PTLDS unclear but one possibility infection B. burgdorferi. burgdorferi known develop morphological variant forms such as round bodies aggregated biofilm-like microcolonies log phase culture consisting spirochete form grows into stationary phase. Here we isolated microcolony planktonic (spirochetal body) from found that (SP) (MC) were much more tolerant current antibiotics doxycycline, ceftriaxone cefuroxime than (LOG). In addition, also compared ability mouse arthritis model. Surprisingly, MC particular SP severe an earlier onset inflammation swelling LOG. MC-infected mice showed significant early 9 days post-infection, while LOG did not swelling. At 21 days, group dramatically increased peaked, at this time less group. infected just beginning 21-day only slight 30-day post infection, developed similar severity group, still show However, 35-day all three groups degree Thereafter, waxed waned during 90-day observation. Thus, established new biofilm-inocula mediated visual model could facilitate efficient evaluation treatment regimens infections. Our findings provide insight pathogenesis may have implications understanding failure, due possible biofilm inoculation tick-bite. This biofilm/persister seeding valid different microbial infections developing effective treatments general.

参考文章(22)
Bijaya Sharma, Autumn V. Brown, Nicole E. Matluck, Linden T. Hu, Kim Lewis, Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells. Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 4616- 4624 ,(2015) , 10.1128/AAC.00864-15
Ying Zhang, Persisters, persistent infections and the Yin-Yang model Emerging microbes & infections. ,vol. 3, pp. 1- 10 ,(2014) , 10.1038/EMI.2014.3
Judith Miklossy, Sandor Kasas, Anne D Zurn, Sherman McCall, Sheng Yu, Patrick L McGeer, Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis Journal of Neuroinflammation. ,vol. 5, pp. 40- 40 ,(2008) , 10.1186/1742-2094-5-40
Emir Hodzic, Denise Imai, Sunlian Feng, Stephen W. Barthold, Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice PLoS ONE. ,vol. 9, pp. e86907- ,(2014) , 10.1371/JOURNAL.PONE.0086907
Monica E. Embers, Stephen W. Barthold, Juan T. Borda, Lisa Bowers, Lara Doyle, Emir Hodzic, Mary B. Jacobs, Nicole R. Hasenkampf, Dale S. Martin, Sukanya Narasimhan, Kathrine M. Phillippi-Falkenstein, Jeanette E. Purcell, Marion S. Ratterree, Mario T. Philipp, Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection PLoS ONE. ,vol. 7, pp. e29914- ,(2012) , 10.1371/JOURNAL.PONE.0029914
Jie Feng, Ting Wang, Wanliang Shi, Shuo Zhang, David Sullivan, Paul G Auwaerter, Ying Zhang, Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library Emerging microbes & infections. ,vol. 3, pp. 1- 8 ,(2014) , 10.1038/EMI.2014.53
Adriana Marques, Sam R. Telford, Siu-Ping Turk, Erin Chung, Carla Williams, Kenneth Dardick, Peter J. Krause, Christina Brandeburg, Christopher D. Crowder, Heather E. Carolan, Mark W. Eshoo, Pamela A. Shaw, Linden T. Hu, Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study Clinical Infectious Diseases. ,vol. 58, pp. 937- 945 ,(2014) , 10.1093/CID/CIT939
Paul M Lantos, Chronic Lyme disease: the controversies and the science. Expert Review of Anti-infective Therapy. ,vol. 9, pp. 787- 797 ,(2011) , 10.1586/ERI.11.63
Hillary Crandall, Diane M. Dunn, Ying Ma, R. Mark Wooten, James F. Zachary, John H. Weis, Robert B. Weiss, Janis J. Weis, Gene Expression Profiling Reveals Unique Pathways Associated with Differential Severity of Lyme Arthritis Journal of Immunology. ,vol. 177, pp. 7930- 7942 ,(2006) , 10.4049/JIMMUNOL.177.11.7930